(AMWL) American Well Corporation Porters Five Forces Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(AMWL) American Well Corporation Complete Analysis Pack
A Must-Have Tool for Decision-Makers
This American Well Corporation Porter's Five Forces Analysis helps you understand the competitive pressures shaping the company’s market position and profitability. What you see on this page is a real preview of the actual report content, not just a summary. Buy the full version to get the complete ready-to-use analysis instantly.
Suppliers Bargaining Power
Cloud hosting dependence
Amwell depends on cloud hosting, storage, and network services to keep its telehealth platform up and secure, so large vendors can pressure pricing and service terms. Global cloud infrastructure spending topped about $330 billion in 2024, showing how concentrated this supplier base is. Still, Amwell can cut that power by using multi-year enterprise contracts and standardizing workloads across clouds.
Interoperability and EHR vendors
Amwell depends on links to EHRs, scheduling, and payer workflows, so interoperability vendors can slow installs and raise custom build costs. About 96% of U.S. hospitals use a certified EHR, and the field is still led by a few large vendors, which gives key vendors moderate leverage when hospitals want deep workflow integration. That can lengthen deployment cycles and push up integration spend.
Telehealth hardware providers
Amwell’s telehealth hardware layer depends on specialized makers of carts, peripherals, tablets, and kiosks, so suppliers can push back on price and delivery. Commodity parts are easy to swap, but medical-grade and connected-care devices are not, because they need certifications and tight integration. That makes supply delays and compliance steps a real source of supplier power.
Security and compliance technology
Security and compliance suppliers have meaningful bargaining power for American Well Corporation because healthcare software depends on encryption, identity management, monitoring, and audit tools that are hard to replace fast. IBM’s 2024 Cost of a Data Breach put healthcare at $9.77 million per breach, so buyers pay up for privacy, uptime, and audit readiness. When these tools sit inside the compliance stack, switching costs stay high.
- Embedded tools raise switching costs
- Privacy and uptime drive vendor power
- Audit-ready systems are hard to swap
Clinical network partners
Clinical network partners give American Well Corporation access to clinicians and specialty care it cannot fully build in-house, so their bargaining power is moderate to high. Scarce experts in behavioral health, stroke care, and pediatrics can push for better pay, faster contract terms, and tighter service rules.
This leverage is strongest when patient demand is high and qualified providers are limited. If a partner can cover hard-to-fill visits or meet licensure and quality standards, American Well Corporation has less room to negotiate.
- Scarcity raises partner pricing power.
- Specialty care partners hold more leverage.
- Quality and licensure boost switching costs.
American Well’s Suppliers Hold Real Pricing Power
American Well Corporation faces moderate supplier power because it relies on cloud, security, and EHR vendors that are costly to replace. Healthcare cloud spending is still highly concentrated, and IBM’s 2024 breach study put healthcare losses at $9.77 million per breach, which keeps compliance suppliers firm on price. Clinical network partners also hold leverage when specialty care is scarce.
| Supplier set | Power | Why it matters |
|---|---|---|
| Cloud and security | High | Sticky, mission-critical |
| EHR and workflow | Moderate | Integration costs |
| Clinical partners | Moderate to high | Specialist scarcity |
What is included in the product
Detailed Word Document
Assesses the five competitive forces shaping American Well Corporation’s pricing power, growth, and market risk.
Customizable Excel Spreadsheet
Quickly spot American Well’s competitive pressures in one clear view—saving time on strategic analysis.
Reference Sources
Provides a clear source trail for American Well Corporation, boosting credibility and helping decision-makers verify key claims quickly.
Customers Bargaining Power
Large health system buyers
Large health system buyers have strong leverage over American Well Corporation because Amwell sells into concentrated enterprise accounts, where one contract can cover many sites and clinicians. These customers can push for lower pricing, pilot periods, and service-level guarantees, and they often ask for custom workflows before signing. That power keeps Amwell’s bargaining power with customers high, especially when a few large systems can influence a meaningful share of revenue.
Payer and employer scrutiny
Health plans and employers push for hard ROI, so American Well Corporation must prove higher utilization, lower avoidable care, and better outcomes. In 2024, American Well Corporation reported revenue of about $254 million, showing how tightly pricing power depends on contract wins and renewals. If results miss targets, buyers can cut volume or move spend to another vendor.
Low switching tolerance
Healthcare buyers face real switching costs with American Well Corporation, since moving a telehealth platform means retraining staff, reworking EHR links, and resetting care workflows. Still, customer power stays high at renewal because health systems can compare vendors and push for lower fees after the first rollout is done. Once embedded, buyers want better terms, but they usually avoid a full restart that would disrupt clinicians and patients.
Consolidated procurement teams
Large health systems and national payers now buy for many sites at once, so American Well Corporation faces fewer but much stronger buyers. These consolidated procurement teams can standardize telehealth vendors, push for enterprise-wide contracts, and press for lower fees or better terms. That cuts pricing power and raises switching risk for American Well Corporation.
- Fewer buyers, bigger contracts, tougher talks.
Demand for outcome proof
Customers have more bargaining power when they demand hard proof of results before renewing American Well Corporation contracts. They now want utilization, patient experience, and cost-avoidance data, and if the numbers do not show clear clinical and operating value, renewal risk rises.
That pressure lets buyers push for lower fees, outcome-based pricing, or extra service terms. In telehealth, proof of ROI is not optional anymore; it is the price of staying on the platform.
Proof of value now drives renewals.
Poor results weaken pricing power.
Better data can defend contract terms.
American Well Faces Strong Buyer Power as Big Clients Push for Better Deals
American Well Corporation faces high customer bargaining power because big health systems and payers buy in bulk and can demand lower fees, pilots, and service guarantees.
Renewal talks stay tough since buyers want proof of ROI, and American Well Corporation reported about $254 million of revenue in 2024, so each contract matters.
Switching is costly, but not enough to erase buyer power when clients can compare vendors and pressure pricing.
| Metric | Signal |
|---|---|
| 2024 revenue | About $254 million |
| Buyer concentration | High |
| Switching costs | Meaningful, but limited |
What You See Is What You Get
American Well Corporation Porter's Five Forces Analysis
This preview shows the exact American Well Corporation Porter’s Five Forces Analysis you’ll receive after purchase—no edits, no placeholders, and no surprises. The document is fully formatted and ready to download immediately after payment. What you see here is the final version, so you can buy with confidence knowing it’s the same file you’ll get.
Rivalry Among Competitors
Intense telehealth competition
Amwell faces intense rivalry because telehealth buyers can choose from many credible vendors, including large digital health and virtual care platforms. Competitors press on platform breadth, specialty care, integrations, and enterprise reach, so switching costs stay low and price pressure stays high. This keeps rivalry elevated because health systems and payers can usually compare several strong alternatives for each deal.
Feature race and innovation
Competitive rivalry is intense because buyers expect constant upgrades in scheduling, triage, AI support, analytics, and specialty workflows. In American Well Corporation’s market, enterprise deals often hinge on product depth and rollout speed, not just price. Vendors that ship faster can win renewals and new logo attention, while slower platforms risk churn as health systems compare more feature-rich 2025 offerings.
Enterprise contract battles
Enterprise healthcare software deals are often 3- to 5-year contracts, so each win or loss can move American Well Corporation’s revenue base for years. In RFPs, rivals bundle telehealth, triage, and care navigation to undercut price, which squeezes margins and keeps rivalry high. Renewal risk is the big swing factor: one lost renewal can hit both current bookings and future cash flow.
Integration differentiation
Integration differentiation is a core rivalry point for American Well Corporation because buyers want telehealth that plugs into EHRs, claims, and care workflows with little friction. In U.S. hospitals, EHR use is already above 96%, so smoother setup can decide which vendor gets the bigger enterprise deal.
Competitors spend more on implementation help, interface work, and workflow mapping to win those deployments, which pushes rivalry higher. The result is a race on speed, reliability, and lower IT burden, not just video visit features.
- Deep EHR links reduce customer friction.
- Claims and workflow fit win larger deals.
- Heavy implementation support raises rivalry.
Brand and scale pressure
Brand and scale pressure is heavy for American Well Corporation: big names with stronger brand trust can win enterprise deals faster, especially when buyers want proven uptime, security, and clinical quality. Amwell’s 2024 revenue was about $250 million, far below larger incumbents, so it must sell reliability as much as software.
- Brand trust shortens sales cycles.
- Scale lowers buyer risk fears.
- Small specialists must prove security.
- Clinical quality is a key moat.
Amwell Faces Fierce Telehealth Rivalry and Renewal Risk
Competitive rivalry is high for American Well Corporation because buyers can compare many telehealth vendors on price, EHR links, and rollout speed. Amwell’s 2024 revenue was about $250 million, so it faces bigger rivals with stronger scale and brand trust. In a market where enterprise contracts often run 3 to 5 years, one lost renewal can hit revenue for years.
| Metric | Data |
|---|---|
| American Well Corporation revenue | ~$250 million, 2024 |
| Typical enterprise contract term | 3 to 5 years |
| Main rivalry drivers | Price, integrations, speed |
Substitutes Threaten
In-person care remains dominant
In-person care stays the main substitute for Amwell because patients can still use office visits, urgent care, and emergency departments for the same need. The U.S. has more than 14,000 urgent care centers, so the offline option is easy to reach.
This matters most for complex exams, imaging, procedures, and hands-on follow-up, where telehealth is weaker. That keeps substitute pressure high even as virtual visits save time and travel.
So Amwell must win on access and speed, not just on price, because traditional care still solves the core health problem through a different channel.
EHR-native virtual care tools
Health systems can now use telehealth tools built into their EHR or care management stack, so they do not need a separate vendor like American Well Corporation for every visit. Epic held 42.3% of U.S. acute care beds in 2024, and its native workflow makes add-on virtual care easy to adopt. As these built-in tools add scheduling, messaging, and video, the substitution threat gets stronger and Amwell’s standalone value gets thinner.
Consumer health apps
Consumer health apps are a clear substitute for American Well Corporation on low-acuity care. Patients can use direct-to-consumer apps, symptom checkers, and virtual primary care for faster access, often at lower cost and with a simpler user flow. That pressure is strongest in routine visits, where U.S. telehealth already saw heavy use across millions of visits in 2025.
Phone and messaging care
Phone triage, secure messaging, and asynchronous clinician review are real substitutes for American Well Corporation’s live video visits in routine follow-up and medication questions. These channels are easier to deploy and can handle low-acuity care without scheduling a real-time slot, which puts pressure on video visit volumes.
That matters because telehealth demand is still concentrated in simple use cases, where speed and convenience beat video. If a payer or health system can route a large share of after-visit questions to messaging, American Well Corporation faces lower visit intensity and weaker pricing power.
- Best for routine, low-acuity care
- Cheaper than live video visits
- Reduces demand for synchronous visits
On-site retail and local clinics
Retail clinics, employer clinics, and community clinics give patients walk-in care without changing habits or learning a telehealth workflow, so they stay strong substitutes for American Well Corporation. In dense U.S. markets, where most people live near a clinic or pharmacy, these options raise price and convenience pressure on virtual care. CVS Health and Walgreens still anchor this access point, with CVS reporting 1,100+ MinuteClinic sites.
- Walk-in care is simpler than telehealth setup
- Urban and suburban markets feel it most
- Clinic networks keep substitution pressure high
High Substitute Threat from In-Person Care
Threat of substitutes for American Well Corporation is high because patients can switch to in-person care, which still covers complex exams, imaging, and procedures better than telehealth. U.S. urgent care access is wide, with 14,000+ centers, and Epic held 42.3% of U.S. acute care beds in 2024, easing built-in digital care adoption.
| Substitute | Signal |
|---|---|
| In-person care | 14,000+ urgent care centers |
| Built-in EHR tools | Epic 42.3% bed share |
Entrants Threaten
Cloud lowers entry barriers
Cloud tools cut the cost and time to launch a basic telehealth app, so small startups can enter quickly without heavy servers or data centers. But American Well Corporation still faces high entry friction in enterprise care, where buyers demand HIPAA controls, EHR integration, uptime SLAs, and multi-year contracts, so a low-cost app alone rarely wins large health system deals.
Regulatory and compliance hurdles
Healthcare platforms must meet HIPAA, consent, and data-use rules before they can sell at scale, and 2025 HIPAA civil penalties can reach $71,162 per violation, with an annual cap of $2,134,831 per violation type. That legal load, plus security audits and breach-response controls, makes entry far harder than ordinary software markets.
Integration complexity
Enterprise wins at American Well Corporation are hard to copy because each deal needs links to EHR, scheduling, identity, billing, and payer systems. That integration work takes specialized health IT talent, and Amwell reported $251.4 million in 2024 revenue, showing a large installed base but also a complex support load. New entrants without interoperability skills face slower launches, higher costs, and more risk when scaling.
Trust and reputation barriers
Hospitals and payers buy slowly because they cannot risk downtime or weak clinical quality. That trust gap is a real barrier: American Well Corporation still benefits from proven uptime, references, and clinical workflows that startups must spend years building.
New entrants also face hard proof tests like security, compliance, and integration. With American Well Corporation already operating at scale, buyers are less likely to swap to a vendor without validated performance and a track record in live care settings.
- Trust takes years, not demos.
- References and certifications are mandatory.
- Proven uptime blocks easy entry.
Capital and sales cycle demands
Amwell faces a high barrier from capital and sales-cycle demands: healthcare buyers rarely move fast, so new entrants must fund long product builds, security and compliance work, and often a full enterprise sales team before any revenue lands. That slows customer wins and makes rapid market saturation unlikely. The result is a strong drag on new-entrant threat.
- Long enterprise sales cycles
- High compliance and launch costs
- Heavy patient and provider acquisition spend
- Slow path to scale
High Barriers Keep New Telehealth Entrants in Check
Threat of new entrants is low to moderate for American Well Corporation: basic telehealth apps are cheap to launch, but enterprise care still needs HIPAA controls, EHR links, uptime SLAs, and long buyer trust. In 2025, HIPAA civil penalties can reach $71,162 per violation, with a $2,134,831 annual cap per type. That raises startup costs and slows scaling.
| Barrier | 2025-2026 data |
|---|---|
| HIPAA penalties | Up to $71,162 each |
| Annual cap | $2,134,831 per type |
| Buyer cycle | Multi-year enterprise deals |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.